Zobrazeno 1 - 10
of 24
pro vyhledávání: '"William Biggs"'
Autor:
Ahmed Moustafa, Chao Xie, Ewen Kirkness, William Biggs, Emily Wong, Yaron Turpaz, Kenneth Bloom, Eric Delwart, Karen E Nelson, J Craig Venter, Amalio Telenti
Publikováno v:
PLoS Pathogens, Vol 13, Iss 3, p e1006292 (2017)
The characterization of the blood virome is important for the safety of blood-derived transfusion products, and for the identification of emerging pathogens. We explored non-human sequence data from whole-genome sequencing of blood from 8,240 individ
Externí odkaz:
https://doaj.org/article/5c88d501f78c4317bfaef7eff6886708
Publikováno v:
The CASE Journal.
Research methodology This case was developed from both primary and secondary sources. Primary sources were interviews. The secondary sources include legal opinions and journal articles. Case overview/synopsis In 2012, Scot and his co-owner, both expe
Autor:
William Biggs, Ian Orozco, Georgia Davis, Katrina J. Ruedy, Roy W. Beck, Janet B. McGill, Anuj Bhargava, Davida F. Kruger, Grazia Aleppo, William H. Polonsky, Quang T Nguyen, Laura A. Young, David Price, John B. Buse, Shichun Bao, Ryan Bailey, Peter Calhoun, Guillermo E. Umpierrez, Rodica Pop-Busui, Athena Philis-Tsimikas, K. Jean Lucas, Thomas W. Martens, Richard M. Bergenstal, Anne L. Peters
Publikováno v:
Diabetes Care
OBJECTIVE To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin. RESEARCH DESIGN AND METHODS This multicenter trial had an initial
Autor:
the MOBILE Study Group, Richard M. Bergenstal, David Price, John B. Buse, William H. Polonsky, K. Jean Lucas, William Biggs, Ian Orozco, Quang T. Nguyen, Thomas Martens, Janet B. McGill, Laura Young, Anuj Bhargava, Davida Kruger, Georgia Davis, Guillermo Umpierrez, Shichun Bao, Athena Philis-Tsimikas, Rodica Pop-Busui, Anne L. Peters, Peter Calhoun, Katrina J. Ruedy, Ryan Bailey, Roy W. Beck, Grazia Aleppo
Objective: To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin. Research Design and Methods: Multi-center trial with an initial r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c97690fcfd2439ee569e171c77cde8
https://doi.org/10.2337/figshare.16607969
https://doi.org/10.2337/figshare.16607969
Autor:
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde, Joseph Proietto, Stephen Stranks, Roger Chen, David O'Neal, Alexia Pape, Mark Forbes, Claire Morbey, Anton Luger, Ursula Hanusch, Christoph Schnack, Evelyn Fliesser-Goerzer, Bertram Hoelzl, Christoph Ebenbichler, Rudolf Prager, Luc Van Gaal, Chris Vercammen, Andre Scheen, Francis Duyck, Frank Nobels, Johannes Ruige, Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, Richard Dumas, Irene Hramiak, Thomas Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina Lihn, Jens Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo Valle, Sakari Nieminen, Kirsi Pietilainen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Verges, Sophie Borot, Alfred Penfornis, Thomas Schaum, Diethelm Tschoepe, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, Rolf Goebel, Thomas Behnke, Anette-Gabriele Ziegler, Eva Peterfai, Zsuzsanna Kerenyi, Tamas Oroszlan, Gyula G. Kiss, Laszlo Konyves, Gyorgyi Piros, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, Piermarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban, Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro, Stobschinski de Alba, Carlos Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperon, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velazquez, Fernando Flores Lozano, Jose Gerardo Gonzalez Gonzalez, Pedro Alberto Garcia-Hernandez, Roberto Araujo-Silva, Efrain Villeda - Espinosa, Cristina Mistodie, Daniela Popescu, Ciprian Constantin, Alina Nicolau, Bogdan Popa, Romulus Timar, Cristian Serafinceanu, Ella Pintilei, Alfonso Soto, Margarita Gimenez, Juan Francisco Merino-Torres, Cristobal Morales, Pedro Mezquita, Johan Jendle, Bengt-Olov Tengmark, Jan Eriksson, Magnus Londahl, Bjorn Eliasson, Anthony Gunstone, Simon Heller, Ken Darzy, Peter Mansell, Melanie Davies, Rory Reed, Duncan Browne, Hamish Courtney, Wayne Turner, Mark Blagden, Rory McCrimmon, Richard Bergenstal, Wendy Lane, Kathryn Lucas, Alexander White, Shichun Bao, Judith White, Curtis Jantzi, Neda Rasouli, William Ervin, Lorena Lewy-Alterbaum, Yehuda Handelsman, Bresta Miranda-Palma, Alan Cleland, Raymond Fink, Helena Rodbard, Samer Nakhle, Craig Greenberg, Alan Schorr, Harold Bays, Debra Simmons, Eric Klein, Laurie Kane, Norman Fishman, Eli Ipp, Satish Garg, Anuj Bhargava, Michelle Zaniewski Singh, Julio Rosenstock, James Thrasher, Mark Warren, Laura Young, Vanita Aroda, Jeremy Pettus, David Liljenquist, Robert Busch, Jonathan Wise, David Kayne, William Biggs
Publikováno v:
The Lancet Diabetes & Endocrinology. 5:864-876
Background Dapagliflozin is a sodium-glucose cotransporter-2 inhibitor approved for the treatment of type 2 diabetes. We aimed to assess the efficacy and safety of dapagliflozin as an add-on to adjustable insulin in patients with inadequately control
Autor:
Roy W Beck, Tonya D Riddlesworth, Katrina J Ruedy, Craig Kollman, Andrew J Ahmann, Richard M Bergenstal, Anuj Bhargava, Bruce W Bode, Stacie Haller, Davida F Kruger, Janet B McGill, William Polonsky, David Price, Elena Toschi, Howard Wolpert, Astrid Atakov-Castillo, Edvina Markovic, Stephen Aronoff, Satanya Brooks, Gloria Martinez, Angela Mendez, Theresa Dunnam, Kathy Fitzgerald, Diana Wright, Teck Khoo, Pierre Theuma, Tara Herrold, Debra Thomsen, Richard Bergenstal, Kathleen McCann, Arlene Monk, Char Ashanti, David Liljenquist, Heather Judge, Jean Halford, Davida Kruger, Shiri Levy, Arti Bhan, Terra Cushman, Lameka Dawson, Heather Remtema, Fawn Wolf, James Neifing, Jennifer Murdoch, Susan Staat, Tamara Mayfield, Andrew Ahmann, Bethany Klopfenstein, Farahnaz Joarder, Kathy Hanavan, Jessica Castle, Diana Aby-Daniel, Victoria Morimoto, Donald DeFrang, Bethany Wollam, Janet McGill, Olivia Jordan, Carol Recklein, Mark Kipnes, Terri Ryan, Bruce Bode, Jennifer Boyd, Nitin Rastogi, Katherine Lindmark, William Biggs, Lorena Sandoval, Robin Eifert, Becky Cota, Quang Nguyen, Alejandra Martinez, Cathy Duran, Scott Segel, David Sutton, Miguel Roura, Rebecca Rosenwasser, Jennifer McElveen, Emily Knisely, Anne Johnson, A. Ola Odugbesan, Karla Wardell, Carolyn Paulus, Jack Wahlen, Jon Winkfield, Hilary Wahlen, Emily Hepworth, David Winkfield, Sue Owens, Steven Leichter, Emily Evans, Sarah Konigsberg, Jennifer Rahman, Linda Gaudiani, Natalie Woods, Jesse Cardozo, Kate Wheeler, Jennifer Kane, Terri Eubanks, Katrina Ruedy, Roy W. Beck, Tonya Riddlesworth, Thomas Mouse, Eileen Casal, Claudia Graham
Publikováno v:
The Lancet Diabetes & Endocrinology. 5:700-708
Summary Background The benefit of initiation of insulin pump therapy (continuous subcutaneous insulin infusion; CSII) in patients with type 1 diabetes using continuous glucose monitoring (CGM) has not been studied. We aimed to assess glycaemic outcom
Autor:
Thomas, Martens, Roy W, Beck, Ryan, Bailey, Katrina J, Ruedy, Peter, Calhoun, Anne L, Peters, Rodica, Pop-Busui, Athena, Philis-Tsimikas, Shichun, Bao, Guillermo, Umpierrez, Georgia, Davis, Davida, Kruger, Anuj, Bhargava, Laura, Young, Janet B, McGill, Grazia, Aleppo, Quang T, Nguyen, Ian, Orozco, William, Biggs, K Jean, Lucas, William H, Polonsky, John B, Buse, David, Price, Richard M, Bergenstal, Andrew, Balo
Publikováno v:
JAMA
IMPORTANCE: Continuous glucose monitoring (CGM) has been shown to be beneficial for adults with type 2 diabetes using intensive insulin therapy, but its use in type 2 diabetes treated with basal insulin without prandial insulin has not been well stud
Autor:
William Biggs, Jacob U. Fog, Peter Mouritzen, Adam Baker, Ina K. Dahslveen, Jesper Salomon, Ditte Andreasen
Publikováno v:
Methods. 50:S6-S9
microRNAs are small regulatory RNAs that are currently emerging as new biomarkers for cancer and other diseases. In order for biomarkers to be useful in clinical settings, they should be accurately and reliably detected in clinical samples such as fo